SFEBES2023 Poster Presentations Adrenal and Cardiovascular (78 abstracts)
An international study of the association between local health care resources and acute adrenal insufficiency events in children with congenital adrenal hyperplasia
Xanthippi Tseretopoulou 1,2 , Salma R Ali 1,2 , Jillian Bryce 2 , Amin Nadia 3 , Navoda Atapattu 4 , Tania Bachega 5 , Federico Baronio 6 , Niels H Birkebaek 7 , Walter Bonfig 8 , Hedi Claahsen-Van der Grinten L. 9 , Martine Cools 10 , Luisa de Sanctis 11 , Liat de Vries 12 , Heba Elsedfy 13 , Christa E Flueck 14 , Antony Fu 15 , Guilherme Guaragna-Filho 16 , Tulay Guran 17 , Ayla Guven 18 , Sabine E Hannema 19 , Violeta Iotova 20 , Daniel Konrad 21 , Nina Lenherr-Taube 21 , Marta Korbonits 22 , Nils P Krone 23 , Ruth Krone 24 , Sofia Leka-Emiris 25 , Corina Lichiardopol R 26 , Andrea Luczay 27 , Renata L Markosyan 28 , Inas Mazen 29 , Tatjana Milenkovic 30 , Klaus Mohnike 31 , Uta Neumann 32 , Marek Niedzela 33 , Anna Nordenstrom 34 , Franziska Phan-Hug 35,36 , Sukran Poyrazoglu 37 , Ursina Probst 38 , Tabitha Randell 39 , Ana Vieites 40 , Gianni Russo 41 , Ajay Thankamony 42 , Erica van den Akker 43 , Judith van Eck 43 , Hetty van der Kamp 44 , Malgorzata G Wasniewska 45 & Syed Faisal Ahmed 1,2
1Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK, Glasgow, United Kingdom. 2Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK, Glasgow, United Kingdom. 3Department of Paediatric Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom. 4Lady Ridgeway Hospital, Colombo, Sri Lanka, Colombo, Sri Lanka. 5Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Disciplina de Endocrinologia, Hospital Das Clinicas, Faculdade De Medicina, Universidade de Sao Paulo, São Paulo, Brazil, Sao Paulo, Brazil. 6Department Hospital of Woman and Child, Pediatric Unit, Center for Rare Endocrine Conditions (Endo-ERN), IRCCS - S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy, Bologna, Italy. 7Department of Paediatrics, Aarhus University Hospital, Aarhus N., Denmark, Aarhus, Denmark. 8Department of Paediatrics, Technical University München, D-80804 Munich, Germany and Department of Paediatrics, Klinikum Wels-Grieskirchen, A-4600 Wels, Austria, Munich, Germany. 9Department of Paediatric Endocrinology, Radboud University Medical Centre, Nijmegen Netherlands, Nijmegen, Netherlands. 10Department of Paediatric Endocrinology,University Hospital Ghent, B-9000 Ghent University, Ghent, Belgium, Ghent, Belgium. 11Regina Margherita Children’s Hospital, Pediatric Endocrinology, AOU Citta della Salute e della Scienza, University of Turin, Turin, Italy, Torino, Italy. 12Institute for endocrinology and diabetes, Schneider Children Medical Center of Israel, Petah Tiqvah, Petah Tiqvah, Israel. 13Department of Pediatrics, Ain Shams University, 11566, Cairo, Egypt, Cairo, Egypt. 14Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics and Department of Biomedical Research, Bern University Hospital Inselspital, University of Bern, 3010 Bern, Switzerland, Bern, Switzerland. 15Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong, China. 16Pediatrics Department, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil., Porto Alegre, Brazil. 17Marmara University, Department of Pediatric Endocrinology and Diabetes, 34899 Pendik, Istanbul, Turkey, Istanbul, Turkey. 18University of Health Science, Medical Faculty, Zeynep Kamil Women and Children Hospital, Pediatric Endocrinology Clinic, Istanbul, Turkey, Istanbul, Turkey. 19Emma Children’s Hospital, Amsterdam UMC location Vrije Universiteit Amsterdam, Pediatric Endocrinology, 1081HV Amsterdam, The Netherlands, Amsterdam, Netherlands. 20Department of Paediatrics, Medical University-Varna, UMHAT “Sv. Marina,” 9002 Varna, Bulgaria, Varna, Bulgaria. 21Department of Pediatrics, Division of Endocrinology, University Children’s Hospital Zurich, Zurich, University of Zurich, Switzerland, Zurich, Switzerland. 22Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK, London, United Kingdom. 23University of Sheffield, Sheffield, UK, Sheffield, United Kingdom. 24Birmingham Women’s & Children’s Hospital, Department for Endocrinology & Diabetes, Birmingham, UK, Birmingham, United Kingdom. 25Pediatric Endocrinology Department, P&A Kyriakou Children’s Hospital, Athens, Greece, Athens, Greece. 26Department of Endocrinology, University of Medicine and Pharmacy Craiova, Romania, Craiova, Romania. 27Department of Paediatrics, Semmelweis University, Budapest, Hungary, Budapest, Hungary. 28Department of Endocrinology, YSMU, Yerevan, Armenia, Yerevan, Armenia. 29Department of Clinical Genetics, National Research Center, Cairo, Egypt, Cairo, Egypt. 30Department of Endocrinology, Mother and Child Health Care Institute of Serbia "Dr Vukan Čupić", Belgrade, Serbia, Belgrade, Serbia. 31University of Magdeburg, Magdeburg, Germany, Magdeburg, Germany. 32Centre for Chronic Sick Children, Institute for Experimental Paediatric Endocrinology, Charité - Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany. 33Poznan University of Medical Sciences, Poland Institute of Pediatrics, Department of Pediatric Endocrinology and Rheumatology, Poznan, Poland. 34Karolinska University Hospital, SE-171 77 Stockholm, Sweden, Stockholm, Sweden. 35Paediatric Endocrinology, Hospital EHC-Morges, Switzerland, Morges, Switzerland. 36Paediatric Endocrinology, Hospital Valais-Sion, Switzerland, Sion, Switzerland. 37Istanbul Faculty of Medicine, Department of Paediatrics, Paediatric Endocrinology Unit, Istanbul University, Çapa 34093, Istanbul, Turkey, Istanbul, Turkey. 38Kantonsspital Winterthur, Switzerland, Winterthur, Switzerland. 39Nottingham Children’s Hospital, UK, Nottingham, United Kingdom. 40Centro de Investigaciones Endocrinológicas “Dr César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina, Buenos Aires, Argentina. 41IRCCS Ospedale San Raffaele, Milan,Italy, Milan, Italy. 42Department of Paediatrics, University of Cambridge, Cambridge CB2 2QQ, UK, Cambridge, United Kingdom. 43Sophia Children’s Hospital, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands; Leiden University Medical Center, 2300 RC Leiden, The Netherlands, Leiden, Netherlands. 44Wilhelmina Kinderziekenhuis, Division of Pediatric Endocrinology, Utrecht, The Netherlands, Utrecht, Netherlands. 45Pediatric Unit, Department of Human Pathology of Adulthood and Childhood, University of Messina, Italy, Messina, Italy
Background: The reported occurrence and management of acute adrenal insufficiency–related adverse events in children vary widely between centres and may depend on available resources.
Methods: Real world data from the I-CAH Registry from 44 centres [32 from high income (HIC) and 12 from low/middle income (LMIC) countries] and a total number of 607 children were linked to the results of a health care survey of local resources and clinical management of CAH completed by healthcare professionals. Resources included written and steroid emergency plans with one point assigned for each resource.
Results: The median reported rate of sick day episodes per patient year per centre at HIC and LMIC centres was 0.69 (range 0, 6) and 0.49 (0,3) respectively (P=0.603). Although the availability of resources for management of adverse events was numerically greater at HIC centres vs LMIC with a median score of 4 (1,7) and 3 (2,6) respectively, this did not reach statistical significance (P=0.109). There was no significant association between the availability of resources and the (sick day episode) SDE rate in LMIC or HIC centres (P=0.195). The use of double dose hydrocortisone was reported more frequently in LMIC vs HIC centres (67% vs 22%, P=0.005). For management of adrenal crises, the most frequently reported medications included parenteral bolus hydrocortisone (100% in HIC vs 75% in LMIC, P=0.003) and saline solution (97% in HIC vs 83% in LMIC, P=0.112). Prednisolone was reported to be used more in LMIC (13% in HIC vs 42% in LMIC, P=0.033).
Conclusions: There is no clear association at centres between the level of resources available and the rate of SDE. However, there are differences in the management of adrenal crises and may reflect local availability of drugs.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more